CHANGE IN HEALTHCARE UTILIZATION AND COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INITIATING ADJUNCTIVE THERAPY WITH SECOND-GENERATION ANTIPSYCHOTICS (SGAS)

被引：1
|
作者：
Hagiwara, M. [1 ]
Sun, S. X. [2 ]
Moynahan, A. [1 ]
Bornheimer, R. [1 ]
Oster, G. [1 ,3 ]
机构：
[1] PAI, Brookline, MA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] MINERVA Hlth Econ Network, Brookline, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.697
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH25
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [1] Second-generation antipsychotics for major depressive disorder and dysthymia
    Komossa, Katja
    Depping, Anna M.
    Gaudchau, Andrea
    Kissling, Werner
    Leucht, Stefan
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (12):
  • [2] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Taneja, C.
    Oster, G.
    Jing, Y.
    Baker, R. A.
    Forbes, R. A.
    Papakostas, G., I
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A113 - A113
  • [3] HEALTHCARE RESOURCE UTILIZATION WITH ADJUNCTIVE CARIPRAZINE AND OTHER ATYPICAL ANTIPSYCHOTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Clayton, A. H.
    Yee, T.
    Sun, H.
    Cummings, N.
    Hayes, O. A.
    Nabulsi, N.
    Parikh, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S104 - S104
  • [4] Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
    Han, Changsu
    Wang, Sheng-Min
    Kato, Masaki
    Lee, Soo-Jung
    Patkar, Ashwin A.
    Masand, Prakash S.
    Pae, Chi-Un
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) : 851 - 870
  • [5] Second-generation antipsychotics in major depressive disorder: update and clinical perspective
    Chen, Jun
    Gao, Keming
    Kemp, David E.
    [J]. CURRENT OPINION IN PSYCHIATRY, 2011, 24 (01) : 10 - 17
  • [6] ADJUNCTIVE ATYPICAL ANTIPSYCHOTIC (AAP) CHOICE AFFECTS HEALTHCARE UTILIZATION IN MAJOR DEPRESSIVE DISORDER (MDD)
    Broder, M. S.
    Greene, M.
    Yan, T.
    Chang, E.
    Hartry, A.
    Yermilov, I
    Duffy, R.
    [J]. VALUE IN HEALTH, 2018, 21 : S78 - S79
  • [7] Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
    Yan, Tingjian
    Greene, Mallik
    Chang, Eunice
    Houle, Christy R.
    Tarbox, Marian H.
    Broder, Michael S.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 81 - 89
  • [8] Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder
    Vincenzi, Brenda
    Greene, Claire M.
    Ulloa, Melissa
    Parnarouskis, Lindsey
    Jackson, John W.
    Henderson, David C.
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2016, 22 (03) : 175 - 182
  • [9] HEALTHCARE COSTS FOR ELDERLY PATIENTS WITH LUNG CANCER AND COMORBID MAJOR DEPRESSIVE DISORDER (MDD)
    Tanudtanud, K.
    Vinculado, R.
    Lasquite, K. M.
    Catlett, K.
    Dacosta, Byfield S.
    [J]. VALUE IN HEALTH, 2021, 24 : S37 - S38
  • [10] CHANGES IN HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH THE USE OF ADJUNCTIVE ATYPICAL ANTIPSYCHOTICS IN MAJOR DEPRESSIVE DISORDER
    Seetasith, A.
    Greene, M.
    Hartry, A.
    Burudpakdee, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S186 - S186
12345